LazyNews
NORMAL
Finance

New pancreatic cancer drug carries a $39,800 monthly list price: What to know - Yahoo Finance

The FDA has approved a new pill for one of the most common forms of pancreatic cancer. What to know about managing the financial impact of a cancer diagnosis...

Share:
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA.  Revolution Medicines' oral tablet daraxonrasib, branded as Rasonque, redu… [+4982 chars]

Community

Comments

Share your perspective. Thoughtful contributions make LazyNews useful.

0 comments

Log in to join the discussion.

Loading comments…